Literature DB >> 24789670

Lower extremity lipedema, upper extremity lipodystrophy and severe calcinosis complicating juvenile dermatomyositis.

Slavica R Pavlov-Dolijanovic1, Nada Z Vujasinovic Stupar, Nikola Gavrilov, Srdjan Seric.   

Abstract

Juvenile dermatomyositis (JDM) is a rare but complex and potentially life-threatening autoimmune disease of childhood. Significant proportions of patients have residual weakness, muscle atrophy, joint contractures, and calcinosis. Recently, new clinical findings, such as lipodystrophy accompanied with increased fat deposition in certain areas, have been reported. So far, it is not known whether the redistribution of body fat may be the type of lipedema of lower extremity. We describe a 39-year-old woman who was diagnosed with JDM at the age of 7. Later she developed symmetrical lipodystrophy of upper extremities and symmetrical lipedema of lower extremities (making 2 and 58.3 % of total body fat mass, respectively), with multiple calcified nodules in the subcutaneous tissues. These nodules gradually increased in size despite therapy. Capillaroscopy findings showed scleroderma-like abnormalities. ANA and anti-U1RNP antibodies were positive. Similar cases with simultaneous occurrence of the lipedema of lower extremities, lipodystrophy of upper extremities, and severe calcinosis complicating JDM have not been published so far. We showed that the calcinosis and lipodystrophy were associated with short duration of active disease. Also, we display case that raises the question whether it is possible overlapping autoimmune diseases revealed during follow-up.

Entities:  

Mesh:

Year:  2014        PMID: 24789670     DOI: 10.1007/s00296-014-3031-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Relative contribution of aging and menopause to changes in lean and fat mass in segmental regions.

Authors:  Tsutomu Douchi; Shinako Yamamoto; Nobuyuki Yoshimitsu; Tetsuo Andoh; Takashi Matsuo; Yukihiro Nagata
Journal:  Maturitas       Date:  2002-08-30       Impact factor: 4.342

2.  Sternal erythema: a distinctive postsurgical eruption.

Authors:  Michael B Morgan; Leigh Ann Scalf; Ruth Hanno
Journal:  J Am Acad Dermatol       Date:  2005-11       Impact factor: 11.527

Review 3.  Classification and treatment of the juvenile idiopathic inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Rheum Dis Clin North Am       Date:  1997-08       Impact factor: 2.670

4.  Inflammatory myopathies in childhood: correlation between nailfold capillaroscopy findings and clinical and laboratory data.

Authors:  Ana K S Nascif; Maria T R A Terreri; Cláudio A Len; Luis E C Andrade; Maria O E Hilário
Journal:  J Pediatr (Rio J)       Date:  2006 Jan-Feb       Impact factor: 2.197

5.  High frequency of calcinosis in juvenile dermatomyositis: a risk factor study.

Authors:  Gleice Clemente; Daniela Gerent Petry Piotto; Cássia Barbosa; Octávio Augusto Peracchi; Claudio Arnaldo Len; Maria Odete Esteves Hilário; Maria Teresa R A Terreri
Journal:  Rev Bras Reumatol       Date:  2012-08

6.  Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification.

Authors:  S L Bowyer; C E Blane; D B Sullivan; J T Cassidy
Journal:  J Pediatr       Date:  1983-12       Impact factor: 4.406

7.  Costal fringe.

Authors:  C R Sartori; E J Baker; E R Hobbs
Journal:  Arch Dermatol       Date:  1991-08

8.  Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.

Authors:  Rita E Fisler; Marilyn G Liang; Robert C Fuhlbrigge; Ali Yalcindag; Robert P Sundel
Journal:  J Am Acad Dermatol       Date:  2002-10       Impact factor: 11.527

9.  [Peri-ungual capillaroscopy in pediatric practice].

Authors:  P Carpentier; P Jeannoel; M Bost; A Franco
Journal:  Pediatrie       Date:  1988

10.  Lipedema, a rare disease.

Authors:  Bae Wook Shin; Young-Joo Sim; Ho Joong Jeong; Ghi Chan Kim
Journal:  Ann Rehabil Med       Date:  2011-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.